Index by author

February 01, 2000; Volume 67,Issue 2

  1. Markman, Maurie

    1. Brain metastases: Presentation, evaluation, and management
      Mark A. Chidel, MD, John H. Suh, MD and Gene H. Barnett, MD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 120-127;

      Prompt diagnosis and treatment can prolong the patient’s life and improve the quality of his or her remaining days.

  2. Mossad, Sherif B.

    1. Antiviral agents for treating influenza
      Jennifer K. Long, PHARMD, Sherif B. Mossad, MD and Morton P. Goldman, PHARMD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 92-95;

      We now have four antiviral drugs for treating influenza. Who should receive them? Which one to use?

  3. Novy, Margareta

    1. Are strict vegetarians at risk of vitamin B<sub>12</sub> deficiency?
      Are strict vegetarians at risk of vitamin B12 deficiency?
      Margareta Novy, MPH, RD, LD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 87;

      Patients who avoid or limit animal products in their diets should be encouraged to take vitamin B12 supplements or eat fortified foods.

  4. Roe, Matthew T.

    1. Glycoprotein Ilb/IIIa inhibitors in acute coronary syndromes
      Matthew T. Roe, MD, Shelly K. Sapp, MS and A. Michael Lincoff, MD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 131-140;

      These potent antiplatelet agents constitute a breakthrough, hut questions remain about their safety, cost-effectiveness, and proper empiric use. With an illustration explaining the paradoxical prothrombotic effect of fibrinolytic drugs.

  5. Saadeh, Sherif

    1. The spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitis
      Sherif Saadeh, MD and Zobair M. Younossi, MD, MPH
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 96-104;

      This recently discovered disease is a common cause of elevated liver enzymes. We are beginning to understand which patients are at greatest risk of progressive liver disease.

  6. Sapp, Shelly K.

    1. Glycoprotein Ilb/IIIa inhibitors in acute coronary syndromes
      Matthew T. Roe, MD, Shelly K. Sapp, MS and A. Michael Lincoff, MD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 131-140;

      These potent antiplatelet agents constitute a breakthrough, hut questions remain about their safety, cost-effectiveness, and proper empiric use. With an illustration explaining the paradoxical prothrombotic effect of fibrinolytic drugs.

  7. Suh, John H.

    1. Brain metastases: Presentation, evaluation, and management
      Mark A. Chidel, MD, John H. Suh, MD and Gene H. Barnett, MD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 120-127;

      Prompt diagnosis and treatment can prolong the patient’s life and improve the quality of his or her remaining days.

  8. Vidt, Donald G.

    1. Is there an advantage to combination therapy with ACE inhibitors and angiotensin II-receptor blockers?
      Donald G. Vidt, MD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 89-91;

      Theoretic reasons and small studies suggest the two types of drugs may be useful in combination, but a definitive answer awaits the results of larger studies.

  9. Wilke, William S.

    1. Is God good for your health? The role of spirituality in medical care
      David B. Larson, MD, MSPH and Harold G. Koenig, MD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 80-84;

      Many studies found that religious belief and practice have a positive effect on physical and mental health. Physicians should try to understand and respect their patients’ beliefs.

    2. Antiviral agents for treating influenza
      Jennifer K. Long, PHARMD, Sherif B. Mossad, MD and Morton P. Goldman, PHARMD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 92-95;

      We now have four antiviral drugs for treating influenza. Who should receive them? Which one to use?

  10. Younossi, Zobair M.

    1. The spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitis
      Sherif Saadeh, MD and Zobair M. Younossi, MD, MPH
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 96-104;

      This recently discovered disease is a common cause of elevated liver enzymes. We are beginning to understand which patients are at greatest risk of progressive liver disease.

« Previous (Pages : 1 2 ... 2)next »
Back to top

In this issue